Annual CFF
-$576.00 K
+$245.00 K+29.84%
31 December 2023
Summary:
Lumos Pharma annual cash flow from financing activities is currently -$576.00 thousand, with the most recent change of +$245.00 thousand (+29.84%) on 31 December 2023. During the last 3 years, it has fallen by -$384.00 thousand (-200.00%).LUMO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$1.73 M
+$1.73 M+100.00%
30 September 2024
Summary:
Lumos Pharma quarterly cash flow from financing activities is currently $1.73 million, with the most recent change of +$1.73 million (+100.00%) on 30 September 2024. Over the past year, it has increased by +$984.00 thousand (+132.61%).LUMO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$2.46 M
+$2.16 M+715.56%
30 September 2024
Summary:
Lumos Pharma TTM cash flow from financing activities is currently $2.46 million, with the most recent change of +$2.16 million (+715.56%) on 30 September 2024. Over the past year, it has increased by +$3.04 million (+527.60%).LUMO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LUMO Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +132.6% | +527.6% |
| 3 y3 years | -200.0% | +100.0% | +1382.8% |
| 5 y5 years | -2718.2% | +7745.4% | +10000.0% |
LUMO Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -100.8% | -96.9% | -96.7% |
Lumos Pharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.73 M(>+9900.0%) | $2.46 M(+715.6%) |
| June 2024 | - | $0.00(-100.0%) | $302.00 K(-211.0%) |
| Mar 2024 | - | -$5000.00(-100.7%) | -$272.00 K(-52.8%) |
| Dec 2023 | -$576.00 K(-29.8%) | $742.00 K(-270.6%) | -$576.00 K(-67.9%) |
| Sept 2023 | - | -$435.00 K(-24.2%) | -$1.79 M(+6.5%) |
| June 2023 | - | -$574.00 K(+85.8%) | -$1.68 M(+51.4%) |
| Mar 2023 | - | -$309.00 K(-34.9%) | -$1.11 M(+35.4%) |
| Dec 2022 | -$821.00 K(+327.6%) | -$475.00 K(+45.7%) | -$821.00 K(+137.3%) |
| Sept 2022 | - | -$326.00 K(>+9900.0%) | -$346.00 K(+1630.0%) |
| June 2022 | - | -$2000.00(-88.9%) | -$20.00 K(-54.5%) |
| Mar 2022 | - | -$18.00 K(<-9900.0%) | -$44.00 K(-77.1%) |
| Dec 2021 | -$192.00 K(-356.0%) | $0.00(0.0%) | -$192.00 K(+100.0%) |
| Sept 2021 | - | $0.00(-100.0%) | -$96.00 K(-10.3%) |
| June 2021 | - | -$26.00 K(-84.3%) | -$107.00 K(+17.6%) |
| Mar 2021 | - | -$166.00 K(-272.9%) | -$91.00 K(-221.3%) |
| Dec 2020 | $75.00 K(+240.9%) | $96.00 K(-972.7%) | $75.00 K(+7400.0%) |
| Sept 2020 | - | -$11.00 K(+10.0%) | $1000.00(-91.7%) |
| June 2020 | - | -$10.00 K(<-9900.0%) | $12.00 K(-45.5%) |
| Mar 2020 | - | $0.00(-100.0%) | $22.00 K(0.0%) |
| Dec 2019 | $22.00 K(-114.9%) | $22.00 K(>+9900.0%) | $22.00 K(-283.3%) |
| Sept 2019 | - | $0.00(0.0%) | -$12.00 K(-29.4%) |
| June 2019 | - | $0.00(-100.0%) | -$17.00 K(-88.5%) |
| Dec 2018 | -$148.00 K(-100.2%) | -$12.00 K(+140.0%) | -$148.00 K(-100.3%) |
| Sept 2018 | - | -$5000.00(-105.4%) | $55.01 M(-26.7%) |
| June 2018 | - | $93.00 K(-141.5%) | $75.07 M(-0.3%) |
| Mar 2018 | - | -$224.00 K(-100.4%) | $75.29 M(+0.0%) |
| Dec 2017 | $75.29 M | $55.15 M(+175.0%) | $75.29 M(+266.5%) |
| Sept 2017 | - | $20.05 M(+6286.6%) | $20.55 M(+1231.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $314.00 K(-237.7%) | $1.54 M(-8.4%) |
| Mar 2017 | - | -$228.00 K(-156.3%) | $1.68 M(-10.6%) |
| Dec 2016 | $1.88 M(-91.8%) | $405.00 K(-61.5%) | $1.88 M(-75.9%) |
| Sept 2016 | - | $1.05 M(+131.2%) | $7.82 M(-0.3%) |
| June 2016 | - | $455.00 K(-1669.0%) | $7.84 M(-7.0%) |
| Mar 2016 | - | -$29.00 K(-100.5%) | $8.43 M(-63.5%) |
| Dec 2015 | $23.09 M(-31.9%) | $6.34 M(+487.6%) | $23.09 M(+7.3%) |
| Sept 2015 | - | $1.08 M(+3.7%) | $21.52 M(+4.5%) |
| June 2015 | - | $1.04 M(-92.9%) | $20.59 M(+3.3%) |
| Mar 2015 | - | $14.63 M(+206.6%) | $19.93 M(-41.2%) |
| Dec 2014 | $33.89 M(-49.4%) | $4.77 M(+3101.3%) | $33.89 M(-27.7%) |
| Sept 2014 | - | $149.00 K(-61.6%) | $46.86 M(+0.4%) |
| June 2014 | - | $388.00 K(-98.6%) | $46.67 M(+0.1%) |
| Mar 2014 | - | $28.58 M(+61.1%) | $46.62 M(-30.4%) |
| Dec 2013 | $67.00 M(+4343.0%) | $17.74 M(<-9900.0%) | $67.00 M(+35.2%) |
| Sept 2013 | - | -$39.00 K(-111.9%) | $49.55 M(-1.3%) |
| June 2013 | - | $329.00 K(-99.3%) | $50.20 M(-0.4%) |
| Mar 2013 | - | $48.97 M(>+9900.0%) | $50.40 M(+3241.9%) |
| Dec 2012 | $1.51 M(-96.4%) | $295.00 K(-51.3%) | $1.51 M(-96.1%) |
| Sept 2012 | - | $606.00 K(+14.6%) | $38.71 M(+1.7%) |
| June 2012 | - | $529.00 K(+578.2%) | $38.07 M(-10.4%) |
| Mar 2012 | - | $78.00 K(-99.8%) | $42.49 M(+0.3%) |
| Dec 2011 | $42.37 M(+273.8%) | $37.50 M(<-9900.0%) | $42.37 M(+770.0%) |
| Sept 2011 | - | -$34.00 K(-100.7%) | $4.87 M(-0.7%) |
| June 2011 | - | $4.95 M(<-9900.0%) | $4.90 M(<-9900.0%) |
| Mar 2011 | - | -$41.00 K | -$41.00 K |
| Dec 2010 | $11.33 M(-42.3%) | - | - |
| Dec 2009 | $19.63 M(+9.5%) | - | - |
| Dec 2008 | $17.93 M | - | - |
FAQ
- What is Lumos Pharma annual cash flow from financing activities?
- What is the all time high annual CFF for Lumos Pharma?
- What is Lumos Pharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Lumos Pharma?
- What is Lumos Pharma quarterly CFF year-on-year change?
- What is Lumos Pharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Lumos Pharma?
- What is Lumos Pharma TTM CFF year-on-year change?
What is Lumos Pharma annual cash flow from financing activities?
The current annual CFF of LUMO is -$576.00 K
What is the all time high annual CFF for Lumos Pharma?
Lumos Pharma all-time high annual cash flow from financing activities is $75.29 M
What is Lumos Pharma quarterly cash flow from financing activities?
The current quarterly CFF of LUMO is $1.73 M
What is the all time high quarterly CFF for Lumos Pharma?
Lumos Pharma all-time high quarterly cash flow from financing activities is $55.15 M
What is Lumos Pharma quarterly CFF year-on-year change?
Over the past year, LUMO quarterly cash flow from financing activities has changed by +$984.00 K (+132.61%)
What is Lumos Pharma TTM cash flow from financing activities?
The current TTM CFF of LUMO is $2.46 M
What is the all time high TTM CFF for Lumos Pharma?
Lumos Pharma all-time high TTM cash flow from financing activities is $75.29 M
What is Lumos Pharma TTM CFF year-on-year change?
Over the past year, LUMO TTM cash flow from financing activities has changed by +$3.04 M (+527.60%)